Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., +17 more...Jones, R., Jones, R., McKeith, I., Macharouthu, A., O'Brien, J., Sheehan, B., Juszczak, E., Katona, C., Hills, R., Knapp, M.
, Ballard, C., Brown, R. G., Banerjee, S., Adams, J., Johnson, T., Bentham, P. & Phillips, P. P. J.
(2015).
Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses.
The Lancet Neurology,
14(12), 1171-1181.
https://doi.org/10.1016/S1474-4422(15)00258-6
, Ballard, C., Brown, R. G., Banerjee, S., Adams, J., Johnson, T., Bentham, P. & Phillips, P. P. J.
(2015).
Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses.
The Lancet Neurology,
14(12), 1171-1181.
https://doi.org/10.1016/S1474-4422(15)00258-6